Epigenetic Regulation in Amyloid Precursor Protein with Genomic Rearrangements and the Lesch-Nyhan Syndrome

REFERENCES

• Master, C.L.; Simms, G.; Weinman, N.A.; Multhaup, G.; McDonald, B.L.; Beyreuther, K. Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc. Natl. Acad. Sci. USA. 1985, 82, 4245–4249.
   PubMed Web of Science ®Google Scholar
• Thinakaran, G.; Koo, E.H. Amyloid precursor protein trafficking, processing, and function. J. Biol. Chem. 2008, 283, 29615–29619.
   PubMed Web of Science ®Google Scholar
• Turner, P.R.; O’Connor, K.; Tate, W.P.; Abraham, W.C. Roles of amyloid precursor protein and its fragments in regulating neural activity, plasticity and memory. Prog. Neurobiol. 2003, 70, 1–32.
   PubMed Web of Science ®Google Scholar
• Hardy, J.A.; Higgins, G.A. Alzheimer's disease: The amyloid cascade hypothesis. Science 1992, 256, 184–185.
   PubMed Web of Science ®Google Scholar
• Bettens, K.; Sleegers, K.; Van Broeckhoven, C. Current status on Alzheimer disease molecular genetics: From past, to present, to future. Hum. Mol. Genet. 2010, 19, R4–R11.
   PubMed Web of Science ®Google Scholar
• Chen, J.; Wang, M.; Turko, I.V. Quantification of amyloid precursor protein isoforms using quantification concatamer internal standard. Anal. Chem. 2013, 85, 303–307.
   PubMed Web of Science ®Google Scholar
• Nguyen, K.V. Epigenetic regulation in amyloid precursor protein and the Lesch-Nyhan syndrome. Biochem. Biophys. Res. Commun. 2014, 446, 1091–1095.
   PubMed Web of Science ®Google Scholar
• Lesch, M.; Nyhan, W.L. A familial disorder of uric acid metabolism and central nervous system function. Am. J. Med. 1964, 36, 561–570.
   PubMed Web of Science ®Google Scholar
• Patel, P.I.; Framson, P.E.; Caskey, C.T.; Chinault, A.C. Fine structure of the human hypoxanthine phosphoribosyl transferase gene. Mol. Cell. Biol. 1986, 6, 393–403.
   PubMed Web of Science ®Google Scholar
• Fu, R.; Ceballos-Picot, I.; Torres, R.J.; Larovere, L.E.; Yamada, Y.; Nguyen, K.V.; Hegde, M.; Visser, J.E.; Schretlen, D.J.; Nyhan, W.L.; Puig, J.G.; O’Neill, P.J.; Jinnah, H.A. for the Lesch-Nyhan disease international study group. Genotype-phenotype correlations in neurogenetics: Lesch-Nyhan disease as a model disorder. Brain 2014, 137, 1282–1303.
   PubMed Web of Science ®Google Scholar
• Nguyen, K.V.; Naviaux, R.K.; Paik, K.K.; Nyhan, W.L. Novel mutations in the human HPRT gene. Nucleosides Nucleotides Nucleic Acids 2011, 30, 440–445.
   PubMed Web of Science ®Google Scholar
• Lupski, J.R.; Stankiewicz, P. Genomic disorders: Molecular mechanisms for rearrangements and conveyed phenotypes. PLoS Genet. 2005, I, e49.
   Web of Science ®Google Scholar
• Chen, J.M.; Chuzhanova, N.; Stenson, P.D.; Ferec, C.; Cooper, D.N. Complex gene rearrangements caused by serial replication slippage. Hum. Mutat. 2005, 26, 125–134.
   PubMed Web of Science ®Google Scholar
• Wenli, G.; Feng, Z.; Lupski, J.R. Mechanisms for human genomic rearrangements. PathoGenet. 2008, I, 4.
   Google Scholar
• Lupski, J.R. Genomic disorders: Structural features of the genome can lead to DNA rearrangements and human disease traits. Trends Genet. 1998, 14, 417–422.
   PubMed Web of Science ®Google Scholar
• Lupski, J.R. Genomic disorders ten years on. Genome Med. 2009, 1, 42.1–42.11.
   PubMedGoogle Scholar
• Sebat, J.; Lakshmi, B.; Malhotra, D.; Troge, J.; Lee-Martin, C.; Walsh, T.; Yamrom, B.; Yoon, S.; Krasnitz, A.; Kendall, J.; Leotta, A.; Pai, D.; Zhang, R.; Lee, Y.H.; Hicks, J.; Spence, S.J.; Lee, A.T.; Puura, K.; Lehtimaki, T.; Ledbetter, D.; Gregersen, P.K.; Bregman, J.; Scucliffe, J.S.; Jobanputra, V.; Chung, W.; Warburton, D.; King, M.C.; Skuse, D.; Geschwind, D.H.; Gilliam, T.C.; Ye, K.; Wigler, M. Strong association of de novo copy number mutations with autism. Science 2007, 316, 445–449.
   PubMed Web of Science ®Google Scholar
• Lupski, J.R. Schizophrenia: Incriminating genomic evidence Nature 2008, 455, 178–179.
   PubMed Web of Science ®Google Scholar
• Stankiewicz, P.; Beaudet, A.L. Use of array CGH in the evaluation of dysmorphology, malformations, developmental delay, and idiopathic mental retardation. Curr. Opin. Genet. Dev. 2007, 17, 182–192.
   PubMed Web of Science ®Google Scholar
• Lee, J.A.; Lupski, J.R. Genomic rearrangements and gene copy-number alterations as a cause of nervous system disorders. Neuron 2006, 52, 103–121.
   PubMed Web of Science ®Google Scholar
• Cheng, C.L.; Molday, R.S. Interaction of 4.1G and cGMB-gated channels in rod photoreceptor outer segments. J. Cell Sc. 2013, 126, 5725–5734.
   PubMed Web of Science ®Google Scholar
• Brewer, G.J.; Dern, R.J. A new inherited enzymatic deficiency of human erythrocytes: 6-phosphogluconate dehydrogenase deficiency. Am. J. Hum. Genet. 1964, 16, 472–476.
   PubMed Web of Science ®Google Scholar
• Beutler, E.; Kuhl, W.; Gelbart, T. 6-phosphogluconolactonase deficiency, a hereditary erythrocyte enzyme deficiency: Possible interaction with glucose-6-phosphate dehydrogenase deficiency. Proc. Natl. Acad. Sci. USA. 1985, 82, 3876–3878.
   PubMed Web of Science ®Google Scholar
• Thomas, P.; Frederick, W.A. Cis-regulatory elements and epigenetic changes control genomic rearrangements of the IgH locus. Adv. Immunol. 2008, 99, 1–32.
   PubMed Web of Science ®Google Scholar
• Harris, J.C.; Lee, R.R.; Jinnah, H.A.; Wong, D.F.; Yaster, M.; Bryan, R.N. Craniocerebral magnetic resonance imaging measurement and findings in Lesch-Nyhan syndrome. Arch. Neurol. 1998, 55, 547–553.
   PubMed Web of Science ®Google Scholar
• Schretlen, D.J.; Varvaris, M.; Ho, T.E.; Vannrsdall, T.D.; Gordon, B.; Harris, J.C.; Jinnah, H.A. Regional brain volume abnormalities in Lesch-Nyhan disease and its variants: A cross-sectional study. Lancet Neurol. 2013, 12, 1151–1158.
   PubMed Web of Science ®Google Scholar
• Schretlen, D.J.; Varvaris, M.; Tracy, D.; Vannorsdall, T.D.; Gordon, B.; James, C.; Harris, J.C.; Jinnah, H.A. Brain white matter volume abnormalities in Lesch-Nyhan disease and its variants. Neurology 2015, 84, 190–196.
   PubMed Web of Science ®Google Scholar
• Visser, J.E.; Baer, P.R.; Jinnah, H.A. Lesch-Nyhan disease and the basal ganglia. Brain Res. Rev. 2000, 32, 449–475.
   PubMed Web of Science ®Google Scholar
• Ceballos-Picot, I.; Auge, F.; Fu, R.; Bandini, A.O.; Cahu, J.; Chabrol, B.; Aral, B.; de Martinvill, B.; Lecain, J.P.; Jinnah, H.A. Phenotype variation among seven members of one family with deficiency of hypoxanthine-guanine phosphoribosyltransferase. Mol. Genet. Metab. 2013, 110, 268–274.
   PubMed Web of Science ®Google Scholar
• Joseph, J.; Shukitt-Hale, B.; Denisova, A.; Martin, A.; Perry, G.; Smith, M.A. Copernicus revisited: Amyloid beta in Alzheimer's disease. Neurobiol. Aging 2001, 22, 131–146.
   PubMed Web of Science ®Google Scholar
• Bishop, G.M.; Robinson, S.R. The amyloid hypothesis: Let sleeping dogmas lie? Neurobiol. Aging 2002, 23, 1101–1105.
   PubMed Web of Science ®Google Scholar
• Reitz, C. Alzheimer's disease and the amyloid cascade hypothesis: A critical review. Internat. J. Alzheimer's Dis. 2012, 369808, 11 pp, doi: 10.1155/2012/369808.
   Google Scholar
• Gold, G.; Blouin, J.L.; Herrmann, F.R.; Michon, A.; Mulligan, R.; Sail, G.D.; Bouras, C.; Giannakopoulos, P.; Antonarakis, S.E. Specific BACE1 genotypes provide additional risk for late-onset Alzheimer disease in APOE epsilon 4 carriers. Am. J. Med. Genet. B Neuropsychiatr Genet. 2003, 119B, 44–47.
   PubMed Web of Science ®Google Scholar
• Ertekin-Taner, N. Genetics of Alzheimer disease in the pre-and post-GWAS era. Alzheimer's Research & Therapy 2010, 2, 3.
   PubMed Web of Science ®Google Scholar
• Lambert, J.C.; Amouyel, P. Genetic heterogeneity of Alzheimer's disease: Complexity and advances. Psychoneuroendocrinology 2007, 32(Suppl. 1), S62–S70.
   PubMed Web of Science ®Google Scholar
• Alagiakrishman, K.; Gill, S.S.; Fagarasanu, A. Genetics and epigenetics of Alzheimer's disease. Postgrad. Med. J. 2012, 88, 522–529.
   PubMed Web of Science ®Google Scholar
• Moore, J.H. The ubiquitous nature of epistasis in determining susceptibility to common human diseases. Hum. Hered. 2003, 56, 73–82.
   PubMed Web of Science ®Google Scholar
• Combarrros, O.; Borja, M.C.; Smith, A.D.; Lehmann, D.J. Epistasis in sporadic Alzheimer's disease. Neurobiol. Aging 2009, 30, 1333–1349.
   PubMed Web of Science ®Google Scholar
• Bentahir, M.; Nyabi, O.; Verhamme, J.; Tolia, A.; Horre, K.; Wiltfang, J.; Esselmann, H.; De Strooper, B. Presenilin clinical mutations can affect gamma-secretase activity by different mechanisms. J. Neurochem. 2006, 96, 732–742.
   PubMed Web of Science ®Google Scholar
• Graeber, M.B.; Kosel, S.; Egensperger, R.; Banati, R.B.; Muller, U.; Bise, K., Hoff, P.; Moller, H.J.; Fujisawa, K.; Mehraein, P. Rediscovery of the case described by Alois Alzheimer in 1911: Historical, histological and molecular genetic analysis. Neurogenetics 1997, 1, 73–80.
   PubMed Web of Science ®Google Scholar
• Muller, U.; Winter, P.; Graeber, M.B. Alois Alzheimer's case, Auguste D., did not carry the N141I mutation in PSEN2 characteristic of Alzheimer disease in Volga Germans. Arch. Neurol. 2011, 68, 1210–1211.
   PubMed Web of Science ®Google Scholar
• Sokol, D.K.; Chen, D.; Farlow, M.R.; Dunn, D.W.; Maloney, B.; Zimmer, J.A.; Lahiri, D.K. High levels of Alzheimer beta-amyloid precursor protein (APP) in children with severely autistic behavior and aggression. J. Child Neurol. 2006, 2, 444–449.
   Google Scholar
• Ray, B.; Long, J.M.; Sokol, D.K.; Lahiri, D.K. Increased secreted amyloid precursor protein-α (sAPPα) in severe autism: Proposal of a specific, anabolic pathway and putative biomarker. PLoS ONE 2011, 6, e20405.
   PubMed Web of Science ®Google Scholar
• Sokol, D.K.; Maloney, B.; Long, J.M.; Ray, B.; Lahiri, D.K. Autism, Alzheimer disease, and fragile X. APP, FMRP, and mGluR5 are molecular links. Neurology 2011, 76, 1344–1352.
   PubMed Web of Science ®Google Scholar
• Lahiri, D.K.; Sokol, D.K.; Erickson, C.; Ray, B.; Ho, C.Y.; Maloney, B. Autism as early neurodevelopmental disorder: Evidence for an sAPPα-mediated anabolic pathway. Frontiers in Cellular Neuroscience 2013, 7, 1–13.
   PubMed Web of Science ®Google Scholar
• Nguyen, K.V.; Naviaux, R.K.; Paik, K.K.; Nakayama, T.; Nyhan, W.L. Lesch-Nyhan variant syndrome: Real-time RT-PCR for mRNA quantification in variable presentation in three affected family members. Nucleosides Nucleotides Nucleic Acids 2012, 31, 616–629.
   PubMed Web of Science ®Google Scholar
• Bennett, C.F.; Swayze, E.E. RNA targeting therapeutics: Molecular mechanisms of anti-sense oligonucleotides as a therapeutic platform. Annu. Rev. Pharmacol. Toxicol. 2010, 50, 259–293.
   PubMed Web of Science ®Google Scholar
• Saonese, J.A. Antisense therapy, a magic bullet for the treatment of various diseases: Present and future prospects. J. Med. Genet. Genomics 2011, 3, 77–83.
   Google Scholar
• Watts, J.K.; Corey, D.R. Silencing disease genes in the laboratory and the clinic. J. Pathol. 2012, 226, 365–379.
   PubMed Web of Science ®Google Scholar